Effective Tacrolimus Treatment for Patients with Non-Severe Aplastic Anemia That is Refractory/Intolerant to Cyclosporine A: A Retrospective Study.
Yali DuYuzhou HuangWenzhe ZhouXinjian LiuFangfei ChenChen YangMiao ChenJing RuanBing HanPublished in: Drug design, development and therapy (2020)
Our data suggest that tacrolimus is a salvage treatment for patients with NSAA that is refractory or intolerant to CsA.